Cargando…

An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease

AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Ye, Han, Wenjing, Zhou, Linfeng, Gao, Jing, Zhao, Jifeng, Song, Nanshan, Hu, Bin, Yao, Qingyu, Liu, Yumin, Xu, Deen, Lu, Yunnan, Fan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324354/
https://www.ncbi.nlm.nih.gov/pubmed/36852451
http://dx.doi.org/10.1111/cns.14141
_version_ 1785069134258634752
author Hua, Ye
Han, Wenjing
Zhou, Linfeng
Gao, Jing
Zhao, Jifeng
Song, Nanshan
Hu, Bin
Yao, Qingyu
Liu, Yumin
Xu, Deen
Lu, Yunnan
Fan, Yi
author_facet Hua, Ye
Han, Wenjing
Zhou, Linfeng
Gao, Jing
Zhao, Jifeng
Song, Nanshan
Hu, Bin
Yao, Qingyu
Liu, Yumin
Xu, Deen
Lu, Yunnan
Fan, Yi
author_sort Hua, Ye
collection PubMed
description AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To access the alterations of NTN‐1 and DCC during the onset and progression of PD, we first established two subacute and one chronic PD model. Then, we investigated the relationship between the NTN‐1/DCC pathway and cell death in SH‐SY5Y cells. Finally, we conducted correlation studies between plasma NTN‐1 and parkinsonian symptoms in patients to understand how this pathway contributes to PD. RESULTS: We found that the imbalance of NTN‐1 and DCC was a common feature of nigral DA neuron injury in PD mouse models. We investigated that MPP+ inhibited NTN‐1 expression and increased DCC expression in a concentration‐ and time‐dependent manner. We further discovered a significant decrease in plasma NTN‐1 levels and a positive correlation with UPDRS scores in PD patients. CONCLUSION: Our findings confirmed the imbalance of NTN‐1/DCC signaling during nigral degeneration in experimental PD models and found for the first time a correlation of plasma NTN‐1 with PD symptoms in patients.
format Online
Article
Text
id pubmed-10324354
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103243542023-07-07 An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease Hua, Ye Han, Wenjing Zhou, Linfeng Gao, Jing Zhao, Jifeng Song, Nanshan Hu, Bin Yao, Qingyu Liu, Yumin Xu, Deen Lu, Yunnan Fan, Yi CNS Neurosci Ther Original Articles AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To access the alterations of NTN‐1 and DCC during the onset and progression of PD, we first established two subacute and one chronic PD model. Then, we investigated the relationship between the NTN‐1/DCC pathway and cell death in SH‐SY5Y cells. Finally, we conducted correlation studies between plasma NTN‐1 and parkinsonian symptoms in patients to understand how this pathway contributes to PD. RESULTS: We found that the imbalance of NTN‐1 and DCC was a common feature of nigral DA neuron injury in PD mouse models. We investigated that MPP+ inhibited NTN‐1 expression and increased DCC expression in a concentration‐ and time‐dependent manner. We further discovered a significant decrease in plasma NTN‐1 levels and a positive correlation with UPDRS scores in PD patients. CONCLUSION: Our findings confirmed the imbalance of NTN‐1/DCC signaling during nigral degeneration in experimental PD models and found for the first time a correlation of plasma NTN‐1 with PD symptoms in patients. John Wiley and Sons Inc. 2023-02-27 /pmc/articles/PMC10324354/ /pubmed/36852451 http://dx.doi.org/10.1111/cns.14141 Text en © 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Hua, Ye
Han, Wenjing
Zhou, Linfeng
Gao, Jing
Zhao, Jifeng
Song, Nanshan
Hu, Bin
Yao, Qingyu
Liu, Yumin
Xu, Deen
Lu, Yunnan
Fan, Yi
An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title_full An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title_fullStr An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title_full_unstemmed An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title_short An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
title_sort imbalance of netrin‐1 and dcc during nigral degeneration in experimental models and patients with parkinson's disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324354/
https://www.ncbi.nlm.nih.gov/pubmed/36852451
http://dx.doi.org/10.1111/cns.14141
work_keys_str_mv AT huaye animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT hanwenjing animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT zhoulinfeng animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT gaojing animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT zhaojifeng animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT songnanshan animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT hubin animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT yaoqingyu animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT liuyumin animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT xudeen animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT luyunnan animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT fanyi animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT huaye imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT hanwenjing imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT zhoulinfeng imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT gaojing imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT zhaojifeng imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT songnanshan imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT hubin imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT yaoqingyu imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT liuyumin imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT xudeen imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT luyunnan imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease
AT fanyi imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease